AstraZeneca to buy Alexion for $39 billion to expand in immunology
Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.
COVID-19 vaccine makers turn to testing children
Health experts urge more research to help curb transmission and to reopen schools.
How Pfizer delivered a COVID vaccine in record time: Crazy deadlines, a pushy CEO
Albert Bourla and his team overcame unproven science and manufacturing bottlenecks; ‘you’re asking for too much.’
Stop coronavirus spread and don’t let your guard down in winter months: Doctor
Dr. Nicole Saphier on coronavirus in winter months
Coronavirus vaccine should not turn into a partisan battle: Former Obama official
Austan Goolsbee on vaccine, stimulus
To avoid lockdowns, we must stop underestimating asymptomatic coronavirus cases: Doctor
Dr. Patrick Soon-Shiong on athletes getting vaccine, lockdowns
Short-term aid such as stimulus, more testing will help over next few months: Doctor
Dr. Mark McClellan on stimulus, lockdowns
T-cell testing will be further improvement upon coronavirus vaccines: Oxford Immunotec CEO
Peter Wrighton-Smith on coronavirus vaccines
We could see vaccine ‘shots in arms’ as soon as Monday: WH deputy press secretary
Brian Morgenstern on coronavirus vaccine distribution
Pro athletes are considered to get early access to the coronavirus vaccine
Louise Radnofsky discusses pro athletes getting vaccinated
Former FDA official on what side effects to expect from coronavirus vaccine
Former FDA Associate Commissioner on coronavirus vaccine, side effects
GNC now selling at-home coronavirus testing kits
Ryan Ostrom on at-home coronavirus test
Doctor on Pfizer coronavirus vaccine: I have 'full confidence' in its safety
Dr. Natasha Kathuria on Pfizer vaccine
‘Outside chance’ FDA could delay vaccine approval due to allergy concerns: Former HHS secretary
Dr. Tom Price on vaccine approval
I don’t want to see a coronavirus vaccine mandate: Ex-White House physician
Ronny Jackson on coronavirus vaccine
The 'Covid-nator' robot is being used around the world to fight coronavirus
Jeff Flock on the Covid-nator
How the US is preparing for the logistics of vaccine distribution
Brandon Daniels on vaccine distribution
How China stands to profit from the coronavirus pandemic
It has been almost a year since global health officials heard word that a new coronavirus, officially termed COVID-19, had emanated from the Chinese city of Wuhan. And while much of the world is grappling with crippled economies and the second wave of infections and deaths, analysts and economists project that Beijing is already standing to gain from the devastation long before the dust has settled.
Dyadic International CEO: Our technology can manufacture 1B doses of vaccine per month
Mark Emalfarb on coronavirus vaccine
Texas launching rapid coronavirus testing program for small businesses
Annie Spilman on small business coronavirus testing program